en

PRODUCT DETAIL

Detreman 1 mg tablety

Code 4053C
MA number 27/0152/17-S
Product Form: tbl 28x1 mg (blis.PA/Al/PVC/Al)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
Therapeutic Class: 27 - ANTIPARKINSONICA
ATC:
N NERVOUS SYSTEM
N04 ANTI-PARKINSON DRUGS
N04B DOPAMINERGIC AGENTS
N04BD Monoamine oxidase B inhibitors
N04BD02 Rasagiline
Shelf life: 36
Container: blister PA/Al/PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 26.05.2017
SPC: SPC_Detreman 1 mg tablety_12.2018.doc  
PIL: PIL_Detreman 1 mg tablety_12.2018.doc  
Safety feature Yes
Data update: 03.01.2022
eu-flag.png sk-flag.png